Are you a mitochondrial disease patient age 12 and older?
Do you have a genetically confirmed primary mitochondrial disease?
Consider participating in the mitoARCH study.
The mitoARCH study is a sub-study of the mitoSHARE registry and is designed to better understand the impact of primary mitochondrial disease (PMD) caused by confirmed DNA mutation on the cognitive abilities of patients.We would like to understand how PMD affects your memory, thinking and how your brain processes information. Results from this study will help us better design clinical trials so we can develop a drug that works on the symptoms most common and most meaningful to patients.
As a participant in the study, you will be asked to:
1. share your medical history by filling out the mitoSHARE surveys
2. complete online questionnaires concerning your experience with fatigue
3. complete 4 electronic cognitive assessments (~30 minutes)
These tasks will be completed in-person, at the UMDF annual conference research pavilion in St. Louis Missouri June 18-20th, 2025. One of the surveys will need to be completed 2 weeks prior to the in-person meeting.
The MitoARCH Study is sponsored by Tisento Therapeutics
Questions? Email registry@umdf.org for more information on the Clinical Research Pavilion.
Bench to Bedside
Ask the Mito Doc